Pierre Marché

845 total citations
46 papers, 654 citations indexed

About

Pierre Marché is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pierre Marché has authored 46 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Physiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pierre Marché's work include Nitric Oxide and Endothelin Effects (9 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Receptor Mechanisms and Signaling (5 papers). Pierre Marché is often cited by papers focused on Nitric Oxide and Endothelin Effects (9 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Receptor Mechanisms and Signaling (5 papers). Pierre Marché collaborates with scholars based in France, China and Serbia. Pierre Marché's co-authors include Philippe Meyer, Sophie Koutouzov, P Meyer, Esma R. Isenović, Dingliang Zhu, Andreja Trpković, P Cuisinier-Gleizes, Mamdouh H. Kedees, Maryvonne Baudouin-Legros and Yuzhen Zhang and has published in prestigious journals such as Biochemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Pierre Marché

45 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Marché France 17 288 158 120 61 57 46 654
Meei Jyh Jiang Taiwan 17 339 1.2× 224 1.4× 170 1.4× 136 2.2× 72 1.3× 30 874
Delphine M. Lees United Kingdom 16 360 1.3× 209 1.3× 86 0.7× 131 2.1× 40 0.7× 33 1.0k
Fernand Gobeil Canada 18 342 1.2× 153 1.0× 82 0.7× 82 1.3× 59 1.0× 23 907
John C. Docherty Canada 14 303 1.1× 129 0.8× 236 2.0× 29 0.5× 63 1.1× 34 701
Lindon Young United States 18 335 1.2× 162 1.0× 194 1.6× 103 1.7× 101 1.8× 59 751
J.A. Lynham United Kingdom 10 387 1.3× 99 0.6× 164 1.4× 28 0.5× 39 0.7× 11 730
T. Padma India 17 459 1.6× 98 0.6× 85 0.7× 34 0.6× 37 0.6× 48 852
Armel Fradin France 10 249 0.9× 89 0.6× 36 0.3× 51 0.8× 67 1.2× 14 524
Mark Bushfield United Kingdom 17 590 2.0× 137 0.9× 77 0.6× 29 0.5× 82 1.4× 32 843
Junichi Takezawa Japan 6 307 1.1× 158 1.0× 129 1.1× 46 0.8× 80 1.4× 12 700

Countries citing papers authored by Pierre Marché

Since Specialization
Citations

This map shows the geographic impact of Pierre Marché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Marché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Marché more than expected).

Fields of papers citing papers by Pierre Marché

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Marché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Marché. The network helps show where Pierre Marché may publish in the future.

Co-authorship network of co-authors of Pierre Marché

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Marché. A scholar is included among the top collaborators of Pierre Marché based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Marché. Pierre Marché is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isenović, Esma R., Sanja Šoškić, Hans‐Dirk Düngen, et al.. (2011). Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions. Cardiovascular & Haematological Disorders - Drug Targets. 11(2). 109–118. 17 indexed citations
2.
Isenović, Esma R., Sanja Šoškić, Andreja Trpković, et al.. (2010). Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation. Current Pharmaceutical Design. 16(35). 3895–3902. 20 indexed citations
3.
Isenović, Esma R., Mamdouh H. Kedees, Snežana Tepavčević, et al.. (2009). Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation. Cardiovascular & Haematological Disorders - Drug Targets. 9(3). 172–180. 40 indexed citations
4.
Isenović, Esma R., Maxence Frétaud, Branislava Dobutović, et al.. (2009). A novel hypothesis regarding the possible involvement of cytosolic phospholipase 2 in insulin‐stimulated proliferation of vascular smooth muscle cells. Cell Biology International. 33(3). 386–392. 6 indexed citations
5.
Isenović, Esma R., et al.. (2008). Insulin regulation of proliferation involves activation of akt and erk 1/2 signaling pathways in vascular smooth muscle cells. 1 indexed citations
6.
7.
Bobe, Régis, et al.. (2003). Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation. American Journal of Physiology-Heart and Circulatory Physiology. 285(2). H745–H754. 28 indexed citations
8.
Zhang, Yuzhen, et al.. (2002). Dual mechanism of action of amlodipine in human vascular smooth muscle cells. Journal of Hypertension. 20(1). 95–102. 32 indexed citations
9.
Zhang, Yuzhen, et al.. (2000). The Inhibitory Mechanisms of Amlodipine in Human Vascular Smooth Muscle Cell Proliferation.. Hypertension Research. 23(4). 403–406. 17 indexed citations
10.
Marché, Pierre, et al.. (2000). Amlodipine inhibits thapsigargin-sensitive Ca2+stores in thrombin-stimulated vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 279(3). H1220–H1227. 25 indexed citations
11.
David‐Dufilho, Monique, Annie Brunet, Fethi Bédioui, et al.. (1999). Superoxide release from interleukin-1β-stimulated human vascular cells: in situ electrochemical measurement. Free Radical Biology and Medicine. 27(5-6). 554–559. 21 indexed citations
12.
Zhu, Dingliang, et al.. (1997). Amlodipine and vascular hypertrophy. International Journal of Cardiology. 62. S79–S84. 10 indexed citations
13.
Zhu, Dingliang, et al.. (1992). Protein Kinase C and Cell Proliferation in Spontaneously Hypertensive Rats. Clinical and Experimental Hypertension Part A Theory and Practice. 14(5). 875–887. 5 indexed citations
14.
Koutouzov, Sophie, Isabelle Limon, & Pierre Marché. (1990). Receptor dependent and -independent protein phosphorylation in platelets of spontaneously hypertensive rats. Thrombosis Research. 59(3). 475–487. 2 indexed citations
15.
Paquet, Jean‐Luc, Maryvonne Baudouin-Legros, Pierre Marché, & Philippe Meyer. (1989). Enhanced Proliferating Activity of Cultured Smooth Muscle Cells From SHR. American Journal of Hypertension. 2(2_Pt_1). 108–110. 32 indexed citations
16.
Baudouin-Legros, Maryvonne, et al.. (1988). Growth rate and phospholipase C activity in cardiac and aortic spontaneously hypertensive rat cells. Journal of Hypertension. 6(4). S369–371. 13 indexed citations
17.
Remmal, Adnane, Sophie Koutouzov, & Pierre Marché. (1988). Enhanced turnover of phosphatidylcholine in platelets of hypertensive rats. Possible involvement of a phosphatidylcholine-specific phospholipase C. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 960(2). 236–244. 5 indexed citations
18.
Koutouzov, Sophie, Isabelle Limon, Philippe Meyer, & Pierre Marché. (1988). Impaired phospholipase C activity is involved in the hyperreactivity of platelets in primary hypertension. Journal of Hypertension. 6(4). S372–374. 4 indexed citations
19.
Rendu, Francine, Pierre Marché, Jacques Viret, et al.. (1987). Signal transduction in normal and pathological thrombin-stimulated human platelets. Biochimie. 69(4). 305–313. 19 indexed citations
20.
Marché, Pierre, et al.. (1985). Phosphoinositide Turnover in Erythrocyte Membranes in Human and Experimental Hypertension. Journal of Hypertension. 3(1). 25–30. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meei Jyh Jiang Breakdown of academic impact, for papers by Delphine M. Lees Breakdown of academic impact, for papers by Fernand Gobeil Breakdown of academic impact, for papers by John C. Docherty Breakdown of academic impact, for papers by Lindon Young Breakdown of academic impact, for papers by J.A. Lynham Breakdown of academic impact, for papers by T. Padma Breakdown of academic impact, for papers by Armel Fradin Breakdown of academic impact, for papers by Mark Bushfield Breakdown of academic impact, for papers by Junichi Takezawa
Rankless by CCL
2026